Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

FPHAX vs IXJ overlap: 36% of top holdings shared

Bottom line

How much do FPHAX and IXJ overlap?

36% of their top holdings overlap by weight. 6 securities appear in both funds' top 25, making up 50.0% of FPHAX's assets and 31.6% of IXJ's. They share a meaningful core but differ in the rest of the portfolio.

IXJ holds far more positions (124 vs 57), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

FPHAXIXJ
Weight overlap (top 25)36%
Shared holdings6
Weight in shared holdings50.0%31.6%
Total positions57124
Expense ratio0.67%0.38%
Holdings as ofMay 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Holdings FPHAX and IXJ have in common

Holding% of FPHAX% of IXJOverlap
ELI LILLY and CO28.78%10.93%10.93%
MERCK and CO INC4.74%4.12%4.12%
Roche Holding Ag4.54%3.75%3.75%
Astrazeneca Plc4.22%3.76%3.76%
Gilead Sciences Inc3.97%2.04%2.04%
JOHNSON and JOHNSON3.77%7.04%3.77%

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in FPHAX

  1. Gsk Plc — 8.17%
  2. Viatris Inc — 5.45%
  3. Ucb Sa — 5.09%
  4. Legend Biotech Corp — 4.53%
  5. Elanco Animal Health Inc — 4.15%
  6. Jazz Pharmaceuticals Plc — 4.09%
  7. Royalty Pharma Plc — 2.67%
  8. Fidelity Revere Street Trust — 2.44%
  9. Moderna Inc — 1.57%
  10. Intellia Therapeutics Inc — 1.19%
  11. Beam Therapeutics Inc — 1.10%
  12. Axsome Therapeutics Inc — 1.08%
  13. Biontech Se — 1.04%
  14. Xenon Pharmaceuticals Inc — 0.82%
  15. Ocular Therapeutix Inc — 0.80%

Only in IXJ

  1. Abbvie Inc. — 5.12%
  2. Unitedhealth Group Incorporated — 4.40%
  3. Novartis AG — 3.71%
  4. Amgen Inc. — 2.54%
  5. Thermo Fisher Scientific Incorporated — 2.42%
  6. Abbott Laboratories — 2.05%
  7. Novo Nordisk A/s — 1.99%
  8. Intuitive Surgical, Inc. — 1.83%
  9. Pfizer Inc. — 1.78%
  10. Cvs Health Corporation — 1.71%
  11. Vertex Pharmaceuticals Incorporated — 1.64%
  12. Danaher Corporation — 1.56%
  13. Bristol-myers Squibb Company — 1.53%
  14. Stryker Corporation — 1.41%
  15. Gsk Plc — 1.38%

Asset mix

Asset typeFPHAXIXJ
Stocks98.7%99.6%
Cash & short-term funds2.6%1.3%
Preferred stock0.7%—
Bonds0.1%—

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Country mix

CountryFPHAXIXJ
US64.8%70.6%
GB15.1%5.8%
CH4.5%10.4%
BE5.3%0.5%
KY4.5%—
IE4.1%1.6%
JP—3.7%
DK0.3%2.3%

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do FPHAX and IXJ overlap?
About 36% by weight. 6 securities appear in both funds' top 25 holdings; they make up 50.0% of FPHAX's assets and 31.6% of IXJ's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do FPHAX and IXJ have in common?
The largest shared holdings are ELI LILLY and CO, MERCK and CO INC, JOHNSON and JOHNSON, Astrazeneca Plc, Roche Holding Ag.
Should I own both FPHAX and IXJ?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, FPHAX or IXJ?
IXJ is broader, with 124 positions versus 57 for FPHAX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.